Similar articles for PMID: 30011904

Year	Number of Results
1948	1
1961	1
1976	1
1996	1
2004	2
2005	4
2006	3
2007	5
2008	7
2009	2
2010	8
2011	5
2012	12
2013	12
2014	5
2015	11
2016	9
2017	13
2018	9
2019	5
2020	3
2021	4
2023	1
2024	0

1

Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations.

Gupta D, Bhatia D, Dave V, Sutariya V, Varghese Gupta S. Gupta D, et al. Molecules. 2018 Jul 14;23(7):1719. doi: 10.3390/molecules23071719. Molecules. 2018. PMID: 30011904 Free PMC article. Review.

2

Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".

Korn C, Balbach S. Korn C, et al. Eur J Pharm Sci. 2014 Jun 16;57:257-63. doi: 10.1016/j.ejps.2013.08.040. Epub 2013 Sep 11. Eur J Pharm Sci. 2014. PMID: 24036162

3

Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.

Elder DP, Holm R, Diego HL. Elder DP, et al. Int J Pharm. 2013 Aug 30;453(1):88-100. doi: 10.1016/j.ijpharm.2012.11.028. Epub 2012 Nov 24. Int J Pharm. 2013. PMID: 23182973 Review.

4

Non-clinical toxicological considerations for pharmaceutical salt selection.

Thackaberry EA. Thackaberry EA. Expert Opin Drug Metab Toxicol. 2012 Nov;8(11):1419-33. doi: 10.1517/17425255.2012.717614. Epub 2012 Sep 6. Expert Opin Drug Metab Toxicol. 2012. PMID: 22950715 Review.

5

An evaluation of salt screening methodologies.

Fernández Casares A, Nap WM, Ten Figás G, Huizenga P, Groot R, Hoffmann M. Fernández Casares A, et al. J Pharm Pharmacol. 2015 Jun;67(6):812-22. doi: 10.1111/jphp.12377. Epub 2015 Feb 14. J Pharm Pharmacol. 2015. PMID: 25683791

6

A case study where pharmaceutical salts were used to address the issue of low in vivo exposure.

Sigfridsson K, Ulvinge ML, Svensson L, Granath AK. Sigfridsson K, et al. Drug Dev Ind Pharm. 2019 Feb;45(2):202-211. doi: 10.1080/03639045.2018.1529184. Epub 2018 Oct 17. Drug Dev Ind Pharm. 2019. PMID: 30256689

7

The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.

He Y, Orton E, Yang D. He Y, et al. J Pharm Sci. 2018 Jan;107(1):419-425. doi: 10.1016/j.xphs.2017.10.032. Epub 2017 Oct 28. J Pharm Sci. 2018. PMID: 29107790

8

Salt formation to improve drug solubility.

Serajuddin AT. Serajuddin AT. Adv Drug Deliv Rev. 2007 Jul 30;59(7):603-16. doi: 10.1016/j.addr.2007.05.010. Epub 2007 May 29. Adv Drug Deliv Rev. 2007. PMID: 17619064 Review.

9

Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.

Cerreia Vioglio P, Chierotti MR, Gobetto R. Cerreia Vioglio P, et al. Adv Drug Deliv Rev. 2017 Aug 1;117:86-110. doi: 10.1016/j.addr.2017.07.001. Epub 2017 Jul 5. Adv Drug Deliv Rev. 2017. PMID: 28687273 Free article. Review.

10

Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper.

Stoimenovski J, MacFarlane DR, Bica K, Rogers RD. Stoimenovski J, et al. Pharm Res. 2010 Apr;27(4):521-6. doi: 10.1007/s11095-009-0030-0. Epub 2010 Feb 9. Pharm Res. 2010. PMID: 20143257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year